COMP <GO>
VTRS vs UNH // 10Y YIELD & FRED MACRO BETA
Viatris Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: VTRS 3
— UNH 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: VTRS
LAST: $19.04 (-0.86%) • MKT CAP: $21.86B
macro-sensitivity
1.15
LAST: $406.97 (-0.96%) • MKT CAP: $365.29B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VTRS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VTRS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.20% | 88.57% | -53.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -8.10% | 11.47% | -19.57 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.78% | 6.47% | +2.31 | VTRS | /fcf-yield <GO> |
| Operating Margin | -18.70% | 4.82% | -23.52 | UNH | /operating-margins <GO> |
| Net Profit Margin | -14.60% | 3.14% | -17.74 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 6.46% | -9.46 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.32% | -2.32 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.81 | 3.12 | -2.31 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.11% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.5 | 57.4 | +5.10 | VTRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.15 | 0.33 | +0.82 | VTRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 17.7x | +15.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.86B | $365.29B | -$343.43B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VTRS REV | UNH REV | VTRS GROSS % | UNH GROSS % | VTRS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.25B | $447.57B | 35.2% | 88.7% | $1.94B | $16.07B |
| FY 2024 | $14.69B | $400.28B | 38.3% | 88.3% | $1.98B | $20.70B |
| FY 2023 | $15.39B | $371.62B | — | 89.6% | $2.21B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VTRS // BETA 1.15
UNH // BETA 0.33